"From your first meeting with your care-management team to ongoing support from our survivorship program long after your treatment is complete, the health care professionals at the Graham Cancer Center are at your service."

During the past decade, Helen F Graham Cancer Center conducted 153 clinical trials. In the 10-year time frame, 153 clinical trials started and 88 clinical trials were completed, i.e. on average, 57.5% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 59 clinical trials were completed. i.e. 151.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Helen F Graham Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 101 trials, followed by "Alliance for Clinical Trials in Oncology" with 34 trials sponsored, "SWOG Cancer Research Network" with 30 trials sponsored, "NRG Oncology" with 22 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 22 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helen F Graham Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 132 trials as a collaborator, "NRG Oncology" with 34 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator and "Sanofi" with 3 trials as a collaborator. Other collaborators include 33 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Helen F Graham Cancer Center" are "Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Lung Cancer AJCC v8" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Breast Cancer" (7 trials). Many other conditions were trialed in "Helen F Graham Cancer Center" in a lesser frequency.

Most popular intervention types in "Helen F Graham Cancer Center" are "Drug" (199 trials), "Other" (161 trials), "Biological" (86 trials), "Procedure" (68 trials) and "Radiation" (58 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (73 trials), "Laboratory Biomarker Analysis" (69 trials), "Questionnaire Administration" (45 trials), "Carboplatin" (30 trials) and "Cisplatin" (29 trials). Other intervention names were less common.

The vast majority of trials in "Helen F Graham Cancer Center" are 206 trials for "All" genders, 47 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Helen F Graham Cancer Center". undefined are not yet recruiting, 70 are recruiting, 112 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Helen F Graham Cancer Center, 8 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Helen F Graham Cancer Center, 15 "Phase 1" clinical trials were conducted, 129 "Phase 2" clinical trials and 142 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".